Arkolith/Insider Trading/ELV/Form 4

Boudreaux Gail

President and CEO, DirectorElevance Health, Inc. (ELV) · full profile →Form 4 · filed Mar 4, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2026Tax withholding(F)2K$284.03$493K169K
Mar 2, 2026Tax withholding(F)7K$294.07$2.0M144K
Mar 2, 2026Grant(A)16K—$0160K
Mar 2, 2026Grant(A)11K—$0171K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Grant(A)64K—$064K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001287920-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML